Clinical Trial Update: Micro-RNA Expression Profiles in High Risk Prostate Cancer

View source ↗

Summary

Clinical trial evaluating micro-RNA expression profiles in high-risk prostate cancer (NCT01220427) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Prostate Cancer, Radical Prostatectomy | Status: TERMINATED